Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib
César Serrano, Sebastian Bauer, David Gómez-Peregrina, Yoon‐Koo Kang, Robin L. Jones, Piotr Rutkowski, Olivier Mir, Michael C. Heinrich, William D. Tap, Kate J. Newberry, A. Grassian, Hang Shi, Steve Bialick, Patrick Schöffski, Maria A. Pantaleo, Margaret von Mehren, Jonathan C. Trent, Suzanne George
Topics & Concepts
PDGFRARegorafenibGiSTMedicineCancer researchImatinibExonStromal tumorTyrosine-kinase inhibitorMutationImatinib mesylateInternal medicineOncologyColorectal cancerStromal cellBiologyCancerGeneticsGeneMyeloid leukemiaGastrointestinal Tumor Research and TreatmentGastrointestinal Bleeding Diagnosis and TreatmentGastrointestinal disorders and treatments